Skip to content

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06004739
Acronym
A-DONUT
Enrollment
550
Registered
2023-08-22
Start date
2024-05-18
Completion date
2027-09-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Disease

Keywords

Delirium, Antibiotics, Older adults, Urinary Tract Infection

Brief summary

Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.

Interventions

DRUGStart Antibiotics / Continue Antibiotics for treatment of bacteriuria

Participants will be randomized to start or continue with antibiotics (with antibiotic duration determined by the Most Responsible Physician \[MRP\]). Antibiotics choice to be selected by the MRP.

OTHERNo Antibiotics for treatment of bacteriuria

Participants will be randomized to no antibiotics

Sponsors

Sault Area Hospital
CollaboratorOTHER
Michael Garron Hospital
CollaboratorOTHER
Unity Health Toronto
CollaboratorOTHER
The Ottawa Hospital
CollaboratorOTHER
Northwestern Memorial Hospital
CollaboratorOTHER
Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 60 and admitted to a hospital ward (including rehabilitation hospital); * Active delirium (defined by CAM: \[1\] inattention AND \[2\] acute and fluctuating level of consciousness, and either \[3\] disorganized thinking OR \[4\] altered mental status; OR physician's diagnosis) * Less than 24 hours of antibiotics (prior to trial assessment) * Either pyuria (defined as white blood cells detected on urinalysis or dipstick) or bacteriuria (defined as bacteria growing on urine culture)

Exclusion criteria

* Fever (temperature \> 37.9C or \> 100.2F) in the past 48 hours; * Signs of lower urinary tract infection symptoms (such as new dysuria) or upper urinary symptoms (such as costovertebral tenderness) * In the opinion of the treating physician, there is a reason apart from delirium and urine test results to treat with antibiotics (e.g., pneumonia) * Indwelling urinary catheter for \> 72 hours * Receipt of an antibiotic where a single dose suffices for the treatment of a UTI (such as Fosfomycin)

Design outcomes

Primary

MeasureTime frameDescription
Delirium at day 7 or at day of hospital discharge, whichever is earliestDelirium will be assessed at the first of day 7 or dischargeDelirium will be assessed using Confusion Assessment Method (CAM). CAM assesses 4 delirium features: \[1\] inattention, \[2\] acute and fluctuating level of consciousness, \[3\] disorganized thinking and \[4\] altered mental status. For a diagnosis of delirium by CAM, the patient must display feature \[1\] AND \[2\], AND EITHER \[3\] or \[4\].

Secondary

MeasureTime frameDescription
Number of participants with bacteremia (bacteria isolated in blood culture)Up to 7 days
Number of participants who were transferred to Intensive Care Unit (ICU)Up to 7 days
Number of participants who had a fallUp to 7 days
Number of participants who were physically restrainedUp to 7 days
Length of hospitalizationUp to 30 days
Days of antibioticsUp to 7 days
Number of participants with C. difficile infectionBy 30 daysC. difficile will be defined as a combination of a positive microbiological test for C. difficile (if still hospitalized at the time of diagnosis), or self-reported diagnosis of C. difficile (provided the patient reported diarrhea and receipt of an antibiotic to treat C. difficile)
Number of participants who diedBy 30 days
Number of participants who were readmitted to hospitalBy 365 days
Number of participants who received antipsychoticsUp to 7 days

Countries

Canada, United States

Contacts

Primary ContactMichael Fralick, MD
mike.fralick@mail.utoronto.ca(416) 586-4800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026